Analystreport

Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "buy" rating re-affirmed by analysts at JPMorgan Chase & Co..

Amicus Therapeutics, Inc.  (FOLD) 
Last amicus therapeutics, inc. earnings: 11/11 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.amicusrx.com/investor-relations